连续性肾脏替代治疗市场基于(关键地区、市场参与者、规模和份额)- 到 2030 年的预测

  • Report Code : TIPHE100001251
  • Category : Medical Device
  • Status : Data Released
  • No. of Pages : 150
Buy Now

[研究报告]持续性肾脏替代治疗市场规模预计将从2022年的14.2亿美元增长到2030年的27.5亿美元。预计2022年至2030年市场复合年增长率为8.7%。
< br>市场洞察和分析师观点:

本报告包括当前连续肾脏替代治疗市场趋势及其在预测期内可预见影响的增长前景。

连续肾脏替代治疗 (CRRT) )是一种挽救生命的干预措施,适用于患有严重急性肾损伤(AKI)、体液超负荷和尿毒症以及可能致命的代谢异常的患者。对儿科 CRRT 设备的需求增加以及导致肾脏疾病的慢性疾病的高患病率等因素推动了肾脏替代治疗市场的持续增长。然而,重大肾脏不良事件 (MAKE) 的重大机会限制了市场增长。

市场驱动因素:

导致肾脏疾病的慢性病发病率高

1全球有 10 人患有慢性肾病 (CKD),这是一种常见且危及生命的疾病。 2015年至2019年,糖尿病和高血压是肾衰竭的两大主要原因,占肾衰竭总数的75%。根据国家肾脏基金会 2020 年发布的估计,在美国 20 岁以上的糖尿病人群中,约 30% 的人一生中有患 CKD 的风险。此外,2020年这种疾病造成的死亡人数比前列腺癌或乳腺癌还要多,而且是一种未被充分认识的紧急健康疾病。三分之一的美国成年人(即约 8000 万人)有 CKD 的风险,现已被确定为 AKI 的明确危险因素。肾小球滤过率 (GFR) 降低和蛋白尿增加与 AKI 密切相关。

根据美国国立卫生研究院的数据,发达国家 AKI 的发生率正在上升。住院患者的患病率预计将达到15%,危重患者的患病率更高,达到60%。全球住院患者 AKI 发生率为 0.7% 至 31%;重症监护病房 (ICU) 患者的发病率超过 50%。 3% 至 13% 的 AKI 患者需要 RRT,其中 40% 的患者预计需要 CRRT 超过 90 天。因此,导致肾脏疾病的慢性疾病的高患病率促进了持续肾脏替代治疗市场的增长。

与 CRRT 相关的主要不良反应包括低血压、心动过速和其他心律失常,这可能会对患者的病情或健康产生不利影响。阻碍他们的康复。此外,CRRT 回路可能有助于更快地清除微量营养素、微量元素和/或治疗药物,这可能导致血液和组织中浓度较低或不规则,从而导致不良反应和/或治疗效果丧失。因此,不良反应限制了连续肾脏替代治疗市场。

战略见解

报告细分和范围:

连续肾脏替代治疗市场分析已由考虑以下细分市场:产品、方式和最终用户。

细分分析:

连续肾脏替代治疗市场按产品细分为透析液和置换液、一次性用品、血统套件和管、CRRT 系统和血液过滤器。 CRRT 系统细分市场在 2022 年占据最大市场份额。血滤器细分市场预计将在 2022 年至 2030 年期间实现最高的复合年增长率。

持续性肾脏替代治疗市场,按产品划分 – 2022 年和2030

按方式,连续性肾脏替代治疗市场分为连续性静脉血液滤过(CVVH)、连续性静脉血液透析滤过(CVVHDF)、连续性静脉血液透析(CVVHD)和缓慢连续超滤(SCUF)。 2022 年,连续静脉静脉血液滤过 (CVVH) 细分市场占据最大市场份额。预计 2022 年至 2030 年,连续静脉静脉血液透析滤过 (CVVHDF) 细分市场的复合年增长率最高。

按最终用户持续性肾脏替代治疗市场分为医院、门诊护理中心、家庭护理等。 2022年,医院细分市场将主导持续性肾脏替代治疗市场份额。然而,家庭监测领域预计在 2022 年至 2030 年期间复合年增长率最高。

区域分析:

连续肾脏替代治疗市场报告的范围涵盖北美(美国、加拿大)和墨西哥)、欧洲(西班牙、英国、德国、法国、意大利和欧洲其他地区)、亚太地区(韩国、中国、印度、日本、澳大利亚和亚太地区其他地区)、中东和非洲(南非)非洲、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)。

就收入而言,2022 年,北美洲美国在连续性肾脏替代治疗市场份额中占据主导地位。预计亚太地区市场在 2022 年至 2030 年期间复合年增长率最高。随着医疗保健基础设施的改善和创新 CRRT 技术的采用,亚太地区的持续肾脏替代治疗市场正在不断增长,这两者都与医疗保健支出的增加有关。此外,市场参与者为扩大在亚太地区的业务而采取的战略举措(例如与当地医疗保健提供商的合作)有利于该地区的市场增长。

竞争格局和主要公司:

连续性肾脏替代治疗市场报告重点关注市场上的知名企业,如百特国际公司、旭化成、费森尤斯医疗、Medica SpA、美敦力公司、贝朗、日机装有限公司、东丽医疗有限公司、Infomed SA、持续肾脏替代治疗市场预测可以帮助利益相关者规划他们的增长战略。这些公司专注于推出新技术、升级现有产品并拓展业务,以满足全球不断增长的消费者需求。

2022 年 4 月,美国食品和药物管理局 (FDA) 为以下产品提供了 510(k) 许可: Baxter International Inc. 的 ST Set 用于连续肾脏替代疗法 (CRRT)。 ST 套件是一种预连接的一次性体外(体外)回路,通过半透膜提供血液净化,与 PrisMax 或 Prismaflex 控制单元(监视器)一起使用。2022 年 3 月,Nipro Medical Corporation (Nipro)肾脏、血管和医疗外科产品的领先制造商和供应商宣布在美国商业推出 SURDIAL DX 血液透析系统。 SURDIAL DX 是最先进的血液透析系统,旨在为患者和临床医生创造最佳的透析治疗体验。该产品在日本制造,基于 Nipro 母公司 Nipro Corporation 超过 35 年的肾脏器械创新专业知识。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region is the fastest growing the continuous renal replacement therapy market?

Asia Pacific is expected to be the fastest-growing region in the continuous renal replacement therapy market. Improving healthcare infrastructure with rising expenditure and the adoption of innovative CRRT technologies bolster the continuous renal replacement therapy market size in Asia Pacific. Additionally, strategic initiatives by the market players to expand their presence in this region, including collaborations with local healthcare providers, favor the market growth in the region.

Which end user segment is dominating the continuous renal replacement therapy market?

The continuous renal replacement therapy market, based on end user, is segmented into hospitals, ambulatory care centers, home care, and others. In 2022, the hospitals segment dominated the continuous renal replacement therapy market share. The home monitoring segment is expected to register the highest CAGR during 2022–2030.

Which product segment is dominating the continuous renal replacement therapy market?

The continuous renal replacement therapy market, based on product, is segmented into dialysates and replacement fluids, disposables, bloodline sets and tubes, CRRT systems, and hemofilters. The CRRT systems segment held the largest share of the market in 2022.

Which modality segment is dominating the continuous renal replacement therapy market?

The continuous renal replacement therapy market, based on modality, is continuous venovenous hemofiltration (CVVH), continuous venovenous hemodiafiltration (CVVHDF), continuous venovenous hemodialysis (CVVHD), and slow continuous ultrafiltration (SCUF). The continuous venovenous hemofiltration (CVVH) segment held the largest share of the market in 2022; however, the continuous venovenous hemodiafiltration (CVVHDF) segment is likely to register the highest CAGR.

Which country is dominating the continuous renal replacement therapy market?

US holds the largest market share in continuous renal replacement therapy market According to the Centers for Disease Control and Prevention in 2021, ~785,000 people in the US were living with end-stage kidney disease also known as end-stage renal disease; 71% out of these were undergoing dialysis while 29% had undergone kidney transplant procedures. As of 2020, there were nearly 7,500 dialysis clinics in the US. The increasing adoption of unhealthy food habits is one of the most prominent risk factor for numerous lifestyle-related disorders such as hypertension, diabetes, and kidney dysfunction.

What are the driving factors for the continuous renal replacement therapy market across the globe?

The factors that are driving the growth of the market are the increased demand for pediatric CRRT devices and the high prevalence of chronic diseases leading to kidney diseases.

Who are the major players in the continuous renal replacement therapy market?

The continuous renal replacement therapy market majorly consists of players such as Baxter International Inc, Asahi Kasei, Fresenius Medical Care, Medica S.p.A., Medtronic Plc, B. Braun, Nikkiso Co Ltd, Toray Medical Co Ltd, Infomed SA, and Quanta Dialysis Technologies Inc.

What is a continuous renal replacement therapy?

Continuous renal replacement therapy is an available renal replacement method that includes intermittent hemodialysis and peritoneal dialysis to provide renal support for critically ill patients with acute kidney injury, mainly patients who are hemodynamically unstable. It is intended to be applied for 24 hours or longer through continuous, slower dialysis. CRRT is performed through pump-driven venovenous extracorporeal circuits and acts as renal support through blood purification to allow solute and fluid homeostasis.

The List of Companies - Continuous Renal Replacement Therapy Market

  1. Baxter International Inc
  2. Asahi Kasei
  3. Fresenius Medical Care
  4. Medica S.p.A.
  5. Medtronic Plc
  6. B. Braun
  7. Nikkiso Co Ltd
  8. Toray Medical Co Ltd
  9. Infomed SA
  10. Quanta Dialysis Technologies Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports